This document discusses key requirements for blood gas laboratories from the College of American Pathologists checklist. It outlines three main learning objectives: 1) developing valid means to compare blood gas analyzers and confirm their measurement ranges, 2) reviewing quality control results to detect instrument differences early, and 3) instituting procedures to detect and prevent preanalytical variation in blood gas results. The document then examines specific checklist items and notes regarding sample collection, instrument calibration and maintenance, proficiency testing, method comparisons, and quality management - emphasizing differences for blood gas analyses given sample instability.
Examines the utility of both arterial and venous blood gas analysis in critical illness
Edward Omron MD MPH FCCP
Pulmonary, Critical Care, and Internal Medicine
Morgan Hill, CA 95037
www.docomron.com
Examines the utility of both arterial and venous blood gas analysis in critical illness
Edward Omron MD MPH FCCP
Pulmonary, Critical Care, and Internal Medicine
Morgan Hill, CA 95037
www.docomron.com
This was a presentation by me for a Seminar For My Pharm. Analysis class. I have tried well to include possible things but haven't gone much in deep because it would be irrelevant as per syllabus. If any mistakes, Please do leave a comment
Gas chromatography head points:
Invention of Chromatography
original chromatography Experiment
Common types of chromatography
Paper and Thin layer chromatography
How does chromatography work?
Theoretical Plate
gas chromatography
schematic of GC
carrier gas-supply
Injection port
sample Injection system
split/spitless Injection
sample valves
GC columns
open tubular columns
Temperature Control
Solid Support Materials
Particle size of Supports
The stationary Phase
Detection systems
Characteristics of the Ideal Detector
Flame Ionization Detectors
Thermal Conductivity Detector
Electron-capture Detectors
https://www.linkedin.com/in/preeti-choudhary-266414182/
https://www.instagram.com/chaudharypreeti1997/
https://www.facebook.com/profile.php?id=100013419194533
https://twitter.com/preetic27018281
Please like, share, comment and follow.
stay connected
If any query then contact:
chaudharypreeti1997@gmail.com
Thanking-You
Preeti Choudhary
This presentation was made to solely for students to make them aware/ understand basics of “Analytical Method Validation”. These slides are part of lectures delivered in M. Pharmacy Curriculum & taken up from various books and websites
Rationale for the reporting and control of degradationDurgadevi Ganesan
Rationale for the reporting and control of degradation, Reporting procedure, Identification of degradation products, Threshold for degradation products in new drug products, Analytical procedure, Reporting degradation products contents of batches.
Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and ...apaari
Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and Enhancement of Trade Opportunities (APRMP), Virtual lab meeting
13 August 2020
Randox QC offer an extensive range of third party quality controls. Manufactured independently, the Acusera range delivers unbiased performance assessment with any instrument or method, helping to meet ISO 15189:2012 requirements whilst simultaneously eliminating the need for multiple instrument dedicated controls.
This was a presentation by me for a Seminar For My Pharm. Analysis class. I have tried well to include possible things but haven't gone much in deep because it would be irrelevant as per syllabus. If any mistakes, Please do leave a comment
Gas chromatography head points:
Invention of Chromatography
original chromatography Experiment
Common types of chromatography
Paper and Thin layer chromatography
How does chromatography work?
Theoretical Plate
gas chromatography
schematic of GC
carrier gas-supply
Injection port
sample Injection system
split/spitless Injection
sample valves
GC columns
open tubular columns
Temperature Control
Solid Support Materials
Particle size of Supports
The stationary Phase
Detection systems
Characteristics of the Ideal Detector
Flame Ionization Detectors
Thermal Conductivity Detector
Electron-capture Detectors
https://www.linkedin.com/in/preeti-choudhary-266414182/
https://www.instagram.com/chaudharypreeti1997/
https://www.facebook.com/profile.php?id=100013419194533
https://twitter.com/preetic27018281
Please like, share, comment and follow.
stay connected
If any query then contact:
chaudharypreeti1997@gmail.com
Thanking-You
Preeti Choudhary
This presentation was made to solely for students to make them aware/ understand basics of “Analytical Method Validation”. These slides are part of lectures delivered in M. Pharmacy Curriculum & taken up from various books and websites
Rationale for the reporting and control of degradationDurgadevi Ganesan
Rationale for the reporting and control of degradation, Reporting procedure, Identification of degradation products, Threshold for degradation products in new drug products, Analytical procedure, Reporting degradation products contents of batches.
Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and ...apaari
Asia Pesticide Residue Mitigation through the Promotion of Biopesticides and Enhancement of Trade Opportunities (APRMP), Virtual lab meeting
13 August 2020
Randox QC offer an extensive range of third party quality controls. Manufactured independently, the Acusera range delivers unbiased performance assessment with any instrument or method, helping to meet ISO 15189:2012 requirements whilst simultaneously eliminating the need for multiple instrument dedicated controls.
Acusera Third Party Quality Controls for Medical Laboratories Randox
With over 350 parameters available in our Acusera range, choice and flexibility is guaranteed. Moreover the availability of truly independent third party controls coupled with the added advantages of highly accurate target values, increased stability and unparalleled quality will optimise performance, save valuable time and minimise waste in any laboratory.
Our comprehensive range of multi-analyte controls have been uniquely developed with ease of use in mind, combining up to 100 parameters in one convenient control laboratories can significantly reduce the need for multiple, costly single analyte controls.
Consolidation
100% human controls for immunoassay purposes
Most accurate target values
Unrivalled stability
Most consistent controls
True third party controls
Preanalytical quality control practices in clinical laboratoryDr. Rajesh Bendre
Preanalytical variables contribute maximally to lab errors. However, these variables are most difficult to control as they include human dependency for phlebotomy skills & pretest patient conditioning. Quantifying & monitoring these variables is also more challenging. Use of checklists, continuous training, competency assessments, internal audits & clinician education for appropriate test utilization form some of the tools for improving the preanalytical processes.
1. It’s a Gas!
Issues in the Blood
Gas Laboratory
D. Robert Dufour, MD, FCAP
Consultant Pathologist
VA Medical Center, Washington DC
2. 2
Learning Objectives
After participating in this session, you will be
able to:
1) Develop valid means for comparing different
blood gas analyzers and for confirming
analytical measurement range.
2) Review QC results to detect important
differences between instruments at an early
time.
3) Institute procedures to detect and prevent
preanalytical variation in blood gas results.
3. 3
Requirements for the
Blood Gas Laboratory
• There are a limited number of questions that
are specific to the blood gas section of the
laboratory
• There are a number of questions in both the
Lab General and Chemistry Checklists that
may have special considerations in the blood
gas lab
• This presentation will attempt to address
issues related to both
4. 4
Sample Collection
• Blood gases are typically collected from
arteries; two questions relate to training
for arterial puncture (CHM.33800) and
procedure itself (CHM.33900)
• Question requires testing for adequate
collateral circulation (such as Allen test),
when appropriate; only applies if lab
staff draw samples
5. 5
Collateral Circulation
• Checklist does not specify a particular
technique for testing collateral circulation,
nor patients in whom it must be done
• Does say that consensus should be
established between clinicians, laboratory
on patients who should be assessed
6. 6
Collateral Circulation
• Can most easily be established by
hospital or lab policy, jointly approved
by medical staff
• Best to document in lab report or
medical record that test was performed
• Also required to specify site of collection
(only mentioned in note)
7. 7
Collateral Circulation
• Issue related to anatomy; in about half
of individuals, palmar arterial arches
incomplete, and in about 4%, loss of
radial artery could compromise blood
supply to the hand
• More of a concern if ulnar blood flow
also compromised, as can occur with
severe atherosclerosis
8. 8
Collateral Circulation
• Henry’s textbook says modified Allen
test should be performed in all patients
prior to radial artery puncture
• Modified Allen test – occlude both ulnar
radial arteries, have clench fist, release
ulnar, open fist: assure adequate flow
by return of red color; can repeat with
radial artery decompression
9. 9
Collateral Circulation
• “Automated” version – more reliable in
hypotensive or unresponsive; use pulse
oximeter on index finger, release ulnar,
should see pulse detected within 15 sec
• Evaluation of oximeter reading itself produces
false positive results (while Allen test has
false negative results), so use of the pulse
sensing portion of pulse oximeters may be
most reliable
10. 10
Ambient Air
• Final sample question requires system
to prevent ambient air contamination
• Air bubbles cause equilibration between
sample and room air.
• This always cause a fall in PCO2 and pH.
• Effect on PO2 depends on treatment;
usually ↑, but may be ↓ if patient on
high FIO2
11. 11
Ambient Air
• Most common cause: air bubbles; effect
of bubbles increased if many small
bubbles, by delay in analysis, or
transported by pneumatic tube
• Policies/procedures should include
sample examination and documentation
of likely erroneous results
12. 12
Instrument Questions
• Only 6 specific questions (CHM.34100-
34600) on blood gas instruments; these
apply in a lab doing blood gases and
other chemistry tests with same director
(even if in separate location(s))
• If physically separate lab, separate
director, then full Chemistry Checklist
must be evaluated for blood gas lab
13. 13
Instrument Questions
• CHM.34100 – Straightforward function
checks – assure you have
documentation of maintenance, etc.
• CHM.34200 – Calibrators meet
manufacturer’s specifications or NIST
SRM – easily satisfied if use
manufacturer’s calibrators
14. 14
Instrument Questions
• CHM.34300 – Calibration and cal
verification – Must follow manufacturers
recommended schedule if used
regularly; for self-calibrating
instruments, not an issue
• If used infrequently, must be calibrated
each time of use
15. 15
Instrument Questions
• Question also mentions barometric
pressure being considered, if
appropriate; follow manufacturer’s
recommendations in this case
• Note requires some procedure for
verifying reliability of calibration; two
expert reviewers have suggested
deleting or modifying this note
16. 16
Instrument Questions
• CHM.34400, 34500 – At least 1 level of
control every 8 hours; at least 2 levels
of control (high, low) every day
• Defined by 8 hours, day of use for
patient testing
• Can use tonometered material or liquid
commercial controls
17. 17
Instrument Questions
• Except for assayed controls, each lab
must establish own control range based
on their measurements, and not use the
ranges provided (CHM.14000)
• Use of too wide ranges can lead to
failure to detect bias and to higher risk
of PT failure
18. 18
Instrument Questions
• CHM.34560 – Requires one control
sample each time patients are tested
unless auto-calibrated every 30 min
• This would likely apply to instruments
that are used infrequently during the
day, not to an instrument that is used
multiple times during a shift
19. 19
Proficiency Testing
• CHM.10200 requires PT to be
integrated with regular workload; note
suggests best rotated among all those
who regularly perform testing
• Performance can be used as part of
competency testing for employees if
regularly rotated
20. 20
Proficiency Testing
• If more than one instrument used, not
required to be tested on all instruments,
only primary instrument
• Important to pay careful attention to
instructions for handling PT material for
blood gases; results can be adversely
affected if directions not followed
21. 21
Calibration Verification
• CHM.13400 requires criteria for
accuracy of calibration and/or for
calibration verification
• Since blood gas instruments calibrated
very frequently, calibration verification is
not required
22. 22
Sample Acceptability
• CHM.11900 requires lab to have
specified criteria for sample
acceptability
• Note indicates that samples that are
unacceptable can still be reported, but
with laboratory noting that results may
be unreliable because of sample
condition
23. 23
Sample Acceptability
• In blood gas laboratory, common
causes for sample unacceptability are:
• 1) Low volume (esp. with liquid heparin,
causes falsely high PO2)
• 2) Air bubbles (causes falsely high PO2,
falsely low PCO2)
• 3) Inadequate icing/delayed arrival
(causes falsely low pH)
24. 24
Sample Acceptability
• CHM.12000 requires documentation of
action taken on unacceptable samples
• Can be either in patient records (as
result or notation), or in sample error
log/form
• Latter approach makes review easier for
QA purposes
25. 25
Reagent Validation
• CHM.12900 requires that all new lots be
validated before being put into use
• Most easily performed by analyzing
patient samples with old, new lots (we
use same form as for method
comparison done every 6 months, and
same criteria for acceptability)
26. 26
Reagent Validation
• Other materials (QC, for example) can
also be used
• Lab must have documentation that this
behaves similarly to patient samples
• Not as much an issue in blood gas
testing as in many other areas of lab
27. 27
Verify Reportable Range
• Reportable range includes:
– Analytical measurement range (AMR) –
range of values that instrument can report
directly (less accurately called linearity)
– Clinically reportable range (CRR) – range
of values that can be reported with dilution
or concentration of samples; for blood gas
lab, not applicable
28. 28
Analytical Measurement Range
• CHM.13600 requires determination of
AMR before method used, and
reverification at least every 6 months,
using at least 3 samples that span
entire measurement range
• Not required separately if at least 3
calibrators that span range used
29. 29
Analytical Measurement Range
• For PCO2, PO2, difficult to get patient
samples that span measurement range,
and these are not stable on storage
• Various vendors (including CAP)
produce linearity materials that can be
used to verify AMR; in our lab, we use
CAP LN-13 survey for this purpose
30. 30
Analytical Measurement Range
• For most recent survey, ranges covered
were:
– pH: 6.8-8.8, allowed difference ± 0.3%
– PCO2: 12-91.5, allowed difference ± 5%
– PO2: 37-445, allowed difference ± 8%
• Remember, values outside AMR must
be reported > or < limits
31. 31
Method Comparison
• CHM.13800 requires that, if more than
one method used for measuring same
parameter, labs check against each
other at least 2x yearly for patient
results
• Requires development of criteria for
acceptable agreement
32. 32
Method Comparison
• Note indicates patient samples are
preferable, but may not be possible for
unstable analytes if instruments located
at some distance (often an issue with
blood gas instruments/samples)
• If controls or reference material used,
lab must verify they perform similarly to
patient samples
33. 33
Method Comparison
• Does not require that single set of
samples be used to compare all
instruments; may compare instrument 1
and 2 with one set, instrument 1 and 3
with another set
• Criteria should be based on patient care
needs and/or criteria needed to pass
proficiency testing
34. 34
Method Comparison
• Be careful to not use “blanket” criteria
for whole laboratory; for example, in
recent inspection I performed,
acceptable agreement for all tests was
± 10%
• For pH, at target value of 7.40, this
would mean “acceptable” was between
6.66 and 8.14!
35. 35
Method Comparison
• For CAP proficiency testing (based on
CLIA-88 regulations), acceptable
performance is within:
– pH: ± 0.04
– PCO2: ± 5 mm Hg or 8%, whichever is
lower
– PO2: ± 3 s.d.
36. 36
Method Comparison
• Question and note do not specify actual
method to be used or number of
samples; in our lab, we perform this
analysis with 5 samples
• Best to use a range of values (both
normal and abnormal high and low) to
detect any biases
37. 37
Method Comparison
• We use form, fill in test, ID of samples
used, results from different instruments,
and director review of acceptability
• We have a single sheet for each section
on allowable differences between
methods developed by director, based
on typical variation in patients (see Tietz
or Kaplan & Pesce for tables)
38. 38
Reference Intervals
• CHM.15000 requires all results to be
reported with reference intervals
• With point of care instruments, printout
often does not have this information on
it, and is sometimes the only “report”
available to clinicians
• Lab must assure that some form with
reference intervals is attached to report
39. 39
Critical Values
• CHM.15100 requires labs to establish criteria
that require immediate notification
• It is not required that all areas have such
critical values, but it is common for blood
gases to have critical values
• May want to have separate critical values by
age (for example, high PO2 dangerous in
infants, not so in children, adults)
40. 40
Critical Values
• CHM.15200 requires documentation of
prompt notification of physician
• If blood gas lab is under separate
leadership (e.g., respiratory medicine),
important that similar approach used to
what is done in central lab
• Often, critical values are hospital, not
laboratory, policies
41. 41
Carryover
• CHM.24400 requires labs to evaluate
automatic pipetting systems for carryover
• Since blood gas instruments often use
pipetting systems, needs to be done for
these instruments as well
• Protocol involves running high sample
several times, then repeat low sample
42. 42
Carryover
• Degree of difference for low sample
(from when run previously) should be
within lab’s criteria for acceptable
difference between instruments
• Seldom an issue in blood gas lab
because of the limited range of results
obtained, but needs to be done once
43. 43
Quality Management
• A number of questions on QM are found
in lab general section
• Remember that QM provisions apply to
blood gas laboratory, and some QA
monitor must be done if blood gas
section is separate from main laboratory
44. 44
Summary
• If blood gas lab is part of main
laboratory, there are few specific
requirements
• If separate section with different director
(common situation), blood gas lab must
comply with full Chemistry, Lab
General, and Team Leader Checklist
requirements
45. 45
Summary
• Important to note differences in how
some questions apply to blood gas labs
because of differences in type of
samples and their stability
• This session covered some of the most
common areas where these differences
are important